1. Home
  2. WVE vs KSS Comparison

WVE vs KSS Comparison

Compare WVE & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • KSS
  • Stock Information
  • Founded
  • WVE 2012
  • KSS 1962
  • Country
  • WVE Singapore
  • KSS United States
  • Employees
  • WVE N/A
  • KSS N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • KSS Department/Specialty Retail Stores
  • Sector
  • WVE Health Care
  • KSS Consumer Discretionary
  • Exchange
  • WVE Nasdaq
  • KSS Nasdaq
  • Market Cap
  • WVE 915.6M
  • KSS 931.8M
  • IPO Year
  • WVE 2015
  • KSS 1992
  • Fundamental
  • Price
  • WVE $6.50
  • KSS $8.38
  • Analyst Decision
  • WVE Strong Buy
  • KSS Sell
  • Analyst Count
  • WVE 13
  • KSS 13
  • Target Price
  • WVE $20.15
  • KSS $8.38
  • AVG Volume (30 Days)
  • WVE 1.0M
  • KSS 8.0M
  • Earning Date
  • WVE 08-07-2025
  • KSS 08-27-2025
  • Dividend Yield
  • WVE N/A
  • KSS 5.92%
  • EPS Growth
  • WVE N/A
  • KSS N/A
  • EPS
  • WVE N/A
  • KSS 1.09
  • Revenue
  • WVE $104,939,000.00
  • KSS $16,072,000,000.00
  • Revenue This Year
  • WVE N/A
  • KSS N/A
  • Revenue Next Year
  • WVE $1.94
  • KSS N/A
  • P/E Ratio
  • WVE N/A
  • KSS $7.76
  • Revenue Growth
  • WVE N/A
  • KSS N/A
  • 52 Week Low
  • WVE $4.87
  • KSS $6.04
  • 52 Week High
  • WVE $16.74
  • KSS $23.09
  • Technical
  • Relative Strength Index (RSI)
  • WVE 45.10
  • KSS 51.09
  • Support Level
  • WVE $6.67
  • KSS $7.93
  • Resistance Level
  • WVE $7.10
  • KSS $8.50
  • Average True Range (ATR)
  • WVE 0.38
  • KSS 0.43
  • MACD
  • WVE -0.02
  • KSS -0.08
  • Stochastic Oscillator
  • WVE 7.77
  • KSS 23.84

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About KSS Kohl's Corporation

Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.

Share on Social Networks: